Oppenheimer Downgrades Emerson (EMR) to Perform
Tweet Send to a FriendGet Alerts EMR Hot Sheet
Price: $56.94 -0.35%
Rating Summary:
4 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
4 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade EMR Now!
Oppenheimer downgraded Emerson (NYSE: EMR) from Outperform to Perform, citing a lack of high conviction catalysts to drive multiple expansion, and near-term risk associated with exposure to capital spending.
"Initial guidance outlook for msd-hsd EPS growth appears a potentially more opportunistic backdrop for expectations, but does include a combined 17c headwind from pension and overlapping stock compensation plans (partially offset by ~6c favorable from lower restructuring spend, and material restructuring benefits)," the analyst notes. "We also note FY2H12 margins were at significant record levels driven by overall execution, but also unsustainable benefits from higher than normal volume leverage at Process on recovery of sales earlier delayed by Thailand flooding."
For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.
Shares of Emerson closed at $48.95 yesterday, with a 52 week range of $43.59-$53.78.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
"Initial guidance outlook for msd-hsd EPS growth appears a potentially more opportunistic backdrop for expectations, but does include a combined 17c headwind from pension and overlapping stock compensation plans (partially offset by ~6c favorable from lower restructuring spend, and material restructuring benefits)," the analyst notes. "We also note FY2H12 margins were at significant record levels driven by overall execution, but also unsustainable benefits from higher than normal volume leverage at Process on recovery of sales earlier delayed by Thailand flooding."
For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.
Shares of Emerson closed at $48.95 yesterday, with a 52 week range of $43.59-$53.78.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell
- Oppenheimer Downgrades Nordson (NDSN) to Perform
- JPMorgan Downgrades Devon Energy (DVN) to Neutral
Create E-mail Alert Related Categories
Downgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
